Keywords: LSD; lysosomal storage disease; CNS; central nervous system; BBB; blood-brain barrier; ERT; enzyme replacement therapy; GAG; glycosaminoglycans; CSF; cerebrospinal fluid; FDA; food and drug administration; ICV; intracerebroventricular; HLA; human leukocyt
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
The effect of galsulfase enzyme replacement therapy on the growth of patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
Keywords: ASB; Arylsulfatase B; CDC; Centers for Disease Control and Prevention; ERT; Enzyme replacement therapy; GAG; Glycosaminoglycans; MPS VI; Mucopolysaccharidosis VI; uGAG; Urinary glycosaminoglycans; Mucopolysaccharidosis; Mucopolysaccharidosis VI; Maroteaux
Functional characterization of arylsulfatase B mutations in Indian patients with Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI)
Keywords: ARSB; Arylsulfatase B; HGMD; human gene mutation database; MPS; mucopolysaccharidoses; LSD; lysosomal storage disorders; DS; dermatan sulfate; Molecular analysis; Mucopolysaccharidoses type VI; Novel mutation; Functional characterization; Pathogenic varia
Effect of CFTR modifiers on arylsulfatase B activity in cystic fibrosis and normal human bronchial epithelial cells
Keywords: Cystic fibrosis; CFTR; Arylsulfatase B; Chondroitin 4-sulfate; Glycosaminoglycans; Corrector; Potentiator; Interleukin-8; Interleukin-6; Neutrophil migration
Regulation of chondroitin-4-sulfotransferase (CHST11) expression by opposing effects of arylsulfatase B on BMP4 and Wnt9A
Keywords: ARSB; Arylsulfatase B; BMP; Bone morphogenetic protein; C4S; Chondroitin 4-sulfate; ChABC; Chondroitinase ABC; CHST11; Carbohydrate (chondroitin 4) sulfotransferase 11; CHST12; Carbohydrate (chondroitin 4) sulfotransferase 12; CHST15; Carbohydrate (N-acet
Fluorimetric assays for N-acetylgalactosamine-6-sulfatase and arylsulfatase B based on the natural substrates for confirmation of mucopolysaccharidoses types IVA and VI
Keywords: ARSB; arylsulfatase B; DBS; dried blood spots on newborn screening cards; GALNS; N-acetylgalactosamine-6-sulfatase; 4MU; 4-methyl-umbelliferyl; 4MU-Gal-6-S; β-4MU glycoside of galactose-6-sulfate; 4MU-GalNAc-4/6-S; β-4MU glycoside of N-acetylgalactosami
Improving arylsulfatase activity determination in dried blood spots: Screening and diagnostic approaches for Maroteaux-Lamy syndrome (MPS VI)
Keywords: ARSB; arylsulfatase B isoform; AU; arbitrary units; DBS; dried blood spot; EA; enzyme activity; LSD; lysosomal storage disorder; MPS VI; mucopolysaccharidosis type VI; NBS; newborn screening; β-MU; 4-methylumbelliferone; β-MUS; 4-methylumbelliferone sul
Molecular signature of kappa-carrageenan mimics chondroitin-4-sulfate and dermatan sulfate and enables interaction with arylsulfatase B
Keywords: Carrageenan; Chondroitin sulfate; Dermatan sulfate; Arylsulfatase B; ROS; Glycosaminoglycan
Current diagnosis and management of mucopolysaccharidosis VI in the Asia-Pacific region
Keywords: ARSB; arylsulfatase B gene; ASB; arylsulfatase B; BMT; bone marrow transplantation; DBS; dry blood spot; dx; diagnosis; ERT; enzyme replacement therapy; GAG; glycosaminoglycan; HSCT; hematopoietic stem cell transplantation; LSDP; Life Saving Drugs Program
Expert recommendations for the laboratory diagnosis of MPS VI
Keywords: MPS VI; Maroteaux–Lamy syndrome; Diagnosis; Arylsulfatase B; Glycosaminoglycan; Algorithm
Genetic studies in a cluster of Mucopolysaccharidosis Type VI patients in Northeast Brazil
Keywords: Mucopolysaccharidosis VI; Maroteaux-Lamy syndrome; Arylsulfatase B; Founder effect; Population Medical Genetics;
Carotid intima-media thickness is increased in patients with mucopolysaccharidoses
Keywords: C-IMT; carotid intima-media thickness; MPS; mucopolysaccharidosis; GAG; glycosaminoglycan; ERT; enzyme replacement therapy; HSCT; hematopoietic stem cell transplant; CHOC; Children's Hospital of Orange County; IVSd; end-diastolic intraventricular septal t
Clinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VI
Keywords: Mucopolysaccharidosis VI; Hematopoietic stem cell transplantation; Enzyme replacement therapy; Mortality; Arylsulfatase B; Galsulfase
Unraveling the biological mechanisms in Alzheimer's disease - Lessons from genomics
Keywords: Aβ; β-amyloid; ACAN; aggrecan; ACE; angiotensin I converting enzyme; AD; Alzheimer's disease; APOE; apolipoprotein E; APP; amyloid precursor protein; ARSB; Arylsulfatase B; ATXN1; ataxin 1; BCR; breakpoint cluster region; BIN1; bridging integrator 1; BL
Arylsulfatase B regulates interaction of chondroitin-4-sulfate and kininogen in renal epithelial cells
Keywords: Arylsulfatase B; Chondroitin-4-sulfate; Kininogen; Bradykinin; Hypertension; Sulfate; Glycosaminoglycan
Polscy pacjenci z chorobÄ
Maroteaux-Lamy'ego (mukopolisacharydozÄ
typu VI)
Keywords: choroba Maroteaux-Lamy'ego; mukopolisacharydozy; mukopolisacharydoza typu VI; leczenie enzymatyczne; arylosulfataza B; Maroteaux-Lamy syndrome; mucopolysaccharidoses; mucopolysaccharidosis type VI; enzyme replacement therapy; arylsulfatase B;
Development of a functional bioassay for arylsulfatase B using the natural substrates of the enzyme
Keywords: Arylsulfatase B; Bioassay; Natural substrate; Chondroitin sulfate; Dematan sulfate; LIF-CZE;
Increased arylsulfatase B activity in cystic fibrosis cells following correction of CFTR
Keywords: Cystic fibrosis; CFTR; Arylsulfatase B; Chondroitin sulfate; Dermatan sulfate; Sulfatase
Mutational analysis of mucopolysaccharidosis type VI patients undergoing a phase II trial of enzyme replacement therapy
Keywords: Mucopolysaccharidosis type VI; MPS VI; Maroteaux–Lamy syndrome; Arylsulfatase B; ARSB; Mutational analysis
Identification of the molecular defects in Spanish and Argentinian mucopolysaccharidosis VI (Maroteaux–Lamy syndrome) patients, including 9 novel mutations
Keywords: Maroteaux–Lamy syndrome; Mucopolysaccharidosis VI; MPS VI; N-Acetylgalactosamine-4-sulfatase; Arylsulfatase B; ARSB gene; Mutational analysis; Haplotype analysis
Steroid sulfatase, arylsulfatases A and B, galactose-6-sulfatase, and iduronate sulfatase in mammary cells and effects of sulfated and non-sulfated estrogens on sulfatase activity
Keywords: Sulfatase; Steroid sulfatase; Estrogen; Estradiol; Estrone sulfate; Estrone; Arylsulfatase B; Arylsulfatase A; Iduronate sulfatase; Galactose-6-sulfatase; Glycosaminoglycan; Peptidoglycan; Hormone replacement therapy